Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...
Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...
Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...
Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...
Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...
Shake the syringe immediately before use to form a homogeneous suspension. Do not use the vaccine if it cannot be resuspended.Parenteraldrug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if part...
BEXSERO may not protect all vaccine recipients. BEXSERO may not provide protection against all meningococcal serogroup B strains [see Clinical Pharmacology (12.1)]. 5.4 Altered Immunocompetence Some individuals with altered immunocompetence may have reduced immune responses to BEXSERO. Complement Deficiency...
In August 2024, the Food and Drug Administration (FDA) changed the label for the meningococcal serogroup B MenB-4C vaccine (Bexsero) from a 2-dose schedule (intervals of 0 and ≥1 month) to a 2-dose schedule (0 and 6 months) and added a 3-dose schedule (0, 1-2...
Serogroup B is the only major disease-associated capsular group of Neisseria meningitidis for which no protein-polysaccharide conjugate vaccine is available. This has led to the development of multi-component protein-based vaccines that target serogroup B invasive meningococcal disease (IMD), including ...
Complete your patients' MenB series using a vaccine with nearly a decade of experience BEXSERO has a 2-dose schedule for every appropriate patient who follows the 6-month interval.5 More Dosing Info Explore the 4 antigens BEXSERO is the only MenB vaccine that combines 4 different antigenic co...